NSPR Message Board Post 9274978 | InspireMD Inc.
home / stock / nspr / nspr message board
Rali0618
(investorshub)
Posted on: Jun/02/2022 16:09:41
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169035879
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=167338599 mayb
News, Short Squeeze, Breakout and More Instantly...
-
Data demonstrate lowest reported primary endpoint event rate of 1.95% through twelve months post-procedure for any carotid stent or embolic protection device pivotal trial Study results to support a Premarket Approval (PMA) application to FDA in H2 2024 U.S. commercial launch of...
-
- Generated first quarter 2024 CGuard EPS revenue of $1.51 million, an increase of 22.0% over the first quarter of 2023 - - Announced that an abstract detailing one-year outcomes from the C-GUARDIANS IDE clinical trial of CGuard™ Prime has been accepted for presentation at LINC 2...